Kamunting Street Capital Management, L.P. Merck & Co., Inc. Transaction History

Kamunting Street Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $274,292 - $298,496	2,738 New	2,738 $298,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $2.88 Million - $3.39 Million	-50,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $1.93 Million - $2.27 Million	-38,000 Reduced 43.18%	50,000 $3.04 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $2.74 Million - $3.27 Million	53,000 Added 151.43%	88,000 $4.95 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $2.05 Million - $2.21 Million	35,000	35,000 $2.24 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.